No title
Background and Aims: Metabolic dysfunction–associated steatotic liver disease (MASLD) is increasingly prevalent in aging populations. Dietary anthocyanin has been shown to exert metabolic benefits in aging and age-associated metabolic disorders. However, its role in protecting against age-dependent hepatic steatosis and the underlying mechanisms remain poorly defined.Approach and Results: In 18-mo
